Accession | ARO:3004380 |
Definition | Antibiotic adjuvant and serine beta-lactamase inhibitor, often paired with meropenem for clinical use. |
Classification | 5 ontology terms | Show |
Parent Term(s) | 13 ontology terms | Show + is_small_molecule_inhibitor SHV-5 + is_small_molecule_inhibitor SHV-18 + is_small_molecule_inhibitor CTX-M-3 + is_small_molecule_inhibitor CTX-M-14 + is_small_molecule_inhibitor CTX-M-15 + is_small_molecule_inhibitor CMY-2 + is_small_molecule_inhibitor DHA-1 + is_small_molecule_inhibitor MIR-1 + is_small_molecule_inhibitor KPC-2 + is_small_molecule_inhibitor KPC-3 + is_small_molecule_inhibitor SME-2 + is_small_molecule_inhibitor NmcA + boronic acid beta-lactamase inhibitor |
Sub-Term(s) | 1 ontology terms | Show + meropenem-vaborbactam [Antibiotic+Adjuvant] has_part |
Publications | Bush K, et al. 2018. ACS Infect Dis 4(2):84-87 Game Changers: New β-Lactamase Inhibitor Combinations Targeting Antibiotic Resistance in Gram-Negative Bacteria. (PMID 29232103) |